{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T20:18:40Z","timestamp":1767644320446,"version":"3.48.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03617-w","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T17:35:53Z","timestamp":1764610553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of risk factors for non-cardioembolic (large-artery atherosclerotic) cerebral infarction with and without intracranial large vessel occlusion: focus on immune-related markers"],"prefix":"10.1186","volume":"31","author":[{"given":"Yinglian","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"issue":"12","key":"3617_CR1","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1161\/STROKEAHA.109.561787","volume":"40","author":"WS Smith","year":"2009","unstructured":"Smith WS, Lev MH, English JD, et al. Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA. Stroke. 2009;40(12):3834\u201340. https:\/\/doi.org\/10.1161\/STROKEAHA.109.561787.","journal-title":"Stroke"},{"issue":"4","key":"3617_CR2","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.10.021","volume":"27","author":"M Inoue","year":"2018","unstructured":"Inoue M, Noda R, Yamaguchi S, et al. Specific factors to predict large-vessel occlusion in acute stroke patients. J Stroke Cerebrovasc Dis. 2018;27(4):886\u201391. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2017.10.021.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"7","key":"3617_CR3","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1161\/STROKEAHA.119.025344","volume":"50","author":"K Uchida","year":"2019","unstructured":"Uchida K, Yoshimura S, Sakai N, Yamagami H, Morimoto T. Sex differences in management and outcomes of acute ischemic stroke with large vessel occlusion. Stroke. 2019;50(7):1915\u20138. https:\/\/doi.org\/10.1161\/STROKEAHA.119.025344.","journal-title":"Stroke"},{"key":"3617_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116814","volume":"413","author":"T Sato","year":"2020","unstructured":"Sato T, Sato S, Yamagami H, et al. D-dimer level and outcome of minor ischemic stroke with large vessel occlusion. J Neurol Sci. 2020;413:116814. https:\/\/doi.org\/10.1016\/j.jns.2020.116814.","journal-title":"J Neurol Sci"},{"issue":"2","key":"3617_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/10641963.2021.2013490","volume":"44","author":"J Wei","year":"2022","unstructured":"Wei J, Yin R, Li X, Pan X, Ma A. Sex-specific relationship between serum uric acid levels and the prevalence of large vessel occlusion in acute ischemic stroke. Clin Exp Hypertens. 2022;44(2):154\u20138. https:\/\/doi.org\/10.1080\/10641963.2021.2013490.","journal-title":"Clin Exp Hypertens"},{"issue":"1","key":"3617_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.numecd.2021.09.030","volume":"32","author":"J Wei","year":"2022","unstructured":"Wei J, Wang Y, Yang S, Hao Z, Pan X, Ma A. Plasma chromogranin A levels are associated with acute ischemic stroke with anterior circulation large vessel occlusion. Nutr Metab Cardiovasc Dis. 2022;32(1):195\u2013202. https:\/\/doi.org\/10.1016\/j.numecd.2021.09.030.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3617_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101993","volume":"90","author":"S Xue","year":"2023","unstructured":"Xue S, Su Z, Liu D. Immunometabolism and immune response regulate macrophage function in atherosclerosis. Ageing Res Rev. 2023;90:101993. https:\/\/doi.org\/10.1016\/j.arr.2023.101993.","journal-title":"Ageing Res Rev"},{"issue":"8","key":"3617_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105935","volume":"30","author":"M Kolmos","year":"2021","unstructured":"Kolmos M, Christoffersen L, Kruuse C. Recurrent ischemic stroke-a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2021;30(8):105935. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2021.105935.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"3617_CR9","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2019.2.04.","author":"A Lasek-Bal","year":"2019","unstructured":"Lasek-Bal A, Jedrzejowska-Szypulka H, Student S, et al. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis. J Physiol Pharmacol. 2019. https:\/\/doi.org\/10.26402\/jpp.2019.2.04.","journal-title":"J Physiol Pharmacol"},{"issue":"2","key":"3617_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1152\/physiol.00020.2016","volume":"32","author":"B Estevez","year":"2017","unstructured":"Estevez B, Du X. New concepts and mechanisms of platelet activation signaling. Physiology Bethesda. 2017;32(2):162\u201377. https:\/\/doi.org\/10.1152\/physiol.00020.2016.","journal-title":"Physiology Bethesda"},{"issue":"1","key":"3617_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5603\/PJNNS.a2020.0094","volume":"55","author":"M Peycheva","year":"2021","unstructured":"Peycheva M, Deneva T, Zahariev Z. The role of fibrinogen in acute ischaemic stroke. Neurol Neurochir Pol. 2021;55(1):74\u201380. https:\/\/doi.org\/10.5603\/PJNNS.a2020.0094.","journal-title":"Neurol Neurochir Pol"},{"issue":"4","key":"3617_CR12","first-page":"11","volume":"70","author":"V Mehta","year":"2022","unstructured":"Mehta V, Prabhakar R, Kumar R, Jyoti D, Sharma CB. Fibrinogen as a predictor of early neurological deterioration and poor outcome in acute ischemic stroke. J Assoc Physicians India. 2022;70(4):11\u20132.","journal-title":"J Assoc Physicians India"},{"issue":"2","key":"3617_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/1747493019876538","volume":"15","author":"T Ohara","year":"2020","unstructured":"Ohara T, Farhoudi M, Bang OY, Koga M, Demchuk AM. The emerging value of serum D-dimer measurement in the work-up and management of ischemic stroke. Int J Stroke. 2020;15(2):122\u201331. https:\/\/doi.org\/10.1177\/1747493019876538.","journal-title":"Int J Stroke"},{"issue":"3","key":"3617_CR14","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1161\/STROKEAHA.120.031657","volume":"52","author":"A Ramos-Pach\u00f3n","year":"2021","unstructured":"Ramos-Pach\u00f3n A, L\u00f3pez-Cancio E, Bustamante A, et al. D-dimer as predictor of large vessel occlusion in acute ischemic stroke. Stroke. 2021;52(3):852\u20138. https:\/\/doi.org\/10.1161\/STROKEAHA.120.031657.","journal-title":"Stroke"},{"issue":"2","key":"3617_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.5005\/jp-journals-10071-23744","volume":"25","author":"NI Abbas","year":"2021","unstructured":"Abbas NI, Sayed O, Samir S, Abeed N. D-dimer level is correlated with prognosis, infarct size, and NIHSS in acute ischemic stroke patients. Indian J Crit Care Med. 2021;25(2):193\u20138. https:\/\/doi.org\/10.5005\/jp-journals-10071-23744.","journal-title":"Indian J Crit Care Med"},{"issue":"3","key":"3617_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018600","volume":"10","author":"H Hou","year":"2021","unstructured":"Hou H, Xiang X, Pan Y, Li H, Meng X, Wang Y. Association of level and increase in D-dimer with all-cause death and poor functional outcome after ischemic stroke or transient ischemic attack. J Am Heart Assoc. 2021;10(3):e018600. https:\/\/doi.org\/10.1161\/JAHA.120.018600.","journal-title":"J Am Heart Assoc"},{"issue":"16","key":"3617_CR17","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","volume":"288","author":"Homocysteine Studies Collaboration","year":"2002","unstructured":"Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288(16):2015\u201322. https:\/\/doi.org\/10.1001\/jama.288.16.2015.","journal-title":"JAMA"},{"issue":"9","key":"3617_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107498","volume":"9","author":"C Zhong","year":"2014","unstructured":"Zhong C, Lv L, Liu C, et al. High homocysteine and blood pressure related to poor outcome of acute ischemia stroke in Chinese population. PLoS ONE. 2014;9(9):e107498. https:\/\/doi.org\/10.1371\/journal.pone.0107498.","journal-title":"PLoS ONE"},{"issue":"3","key":"3617_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1042\/CS20090142","volume":"118","author":"W Zhang","year":"2009","unstructured":"Zhang W, Sun K, Chen J, et al. High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population. Clin Sci Lond. 2009;118(3):187\u201394. https:\/\/doi.org\/10.1042\/CS20090142.","journal-title":"Clin Sci Lond"},{"issue":"3","key":"3617_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1161\/01.str.28.3.557","volume":"28","author":"SG Wannamethee","year":"1997","unstructured":"Wannamethee SG, Shaper AG, Perry IJ. Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke. Stroke. 1997;28(3):557\u201363. https:\/\/doi.org\/10.1161\/01.str.28.3.557.","journal-title":"Stroke"},{"issue":"6","key":"3617_CR21","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1161\/STROKEAHA.106.474569","volume":"38","author":"AM Carter","year":"2007","unstructured":"Carter AM, Catto AJ, Mansfield MW, Bamford JM, Grant PJ. Predictive variables for mortality after acute ischemic stroke. Stroke. 2007;38(6):1873\u201380. https:\/\/doi.org\/10.1161\/STROKEAHA.106.474569.","journal-title":"Stroke"},{"issue":"2","key":"3617_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000346603","volume":"35","author":"E Chiquete","year":"2013","unstructured":"Chiquete E, Ruiz-Sandoval JL, Murillo-Bonilla LM, et al. Serum uric acid and outcome after acute ischemic stroke: PREMIER study. Cerebrovasc Dis. 2013;35(2):168\u201374. https:\/\/doi.org\/10.1159\/000346603.","journal-title":"Cerebrovasc Dis"},{"issue":"11","key":"3617_CR23","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1016\/j.numecd.2021.07.031","volume":"31","author":"M Zhang","year":"2021","unstructured":"Zhang M, Wang Y, Wang K, Yin R, Pan X, Ma A. Association between uric acid and the prognosis of acute ischemic stroke: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2021;31(11):3016\u201323. https:\/\/doi.org\/10.1016\/j.numecd.2021.07.031.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"3617_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105525","volume":"30","author":"J Derbisz","year":"2021","unstructured":"Derbisz J, Nowak K, Wnuk M, et al. Prognostic significance of stroke-associated infection and other readily available parameters in acute ischemic stroke treated by intravenous thrombolysis. J Stroke Cerebrovasc Dis. 2021;30(2):105525. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.105525.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"9","key":"3617_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107017","volume":"9","author":"Y Liu","year":"2014","unstructured":"Liu Y, Wang J, Zhang L, et al. Relationship between C-reactive protein and stroke: a large prospective community based study. PLoS ONE. 2014;9(9):e107017. https:\/\/doi.org\/10.1371\/journal.pone.0107017.","journal-title":"PLoS ONE"},{"issue":"3","key":"3617_CR26","first-page":"461","volume":"27","author":"S Akhter","year":"2018","unstructured":"Akhter S, Das SN, Sutradhar SR, Basher MS, Khan MK. Level of serum C-reactive protein among patients with stroke. Mymensingh Med J. 2018;27(3):461\u20136.","journal-title":"Mymensingh Med J"},{"issue":"10","key":"3617_CR27","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.05.047","volume":"27","author":"CA Irimie","year":"2018","unstructured":"Irimie CA, V\u00e2rciu M, Irimie M, Ifteni PI, Minea DI. C-reactive protein and T3: new prognostic factors in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2018;27(10):2731\u20137. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.05.047.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"3617_CR28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2174\/1567202615666180712100440","volume":"15","author":"X Zheng","year":"2018","unstructured":"Zheng X, Zeng N, Wang A, et al. Elevated C-reactive protein and depressed high-density lipoprotein cholesterol are associated with poor function outcome after ischemic stroke. Curr Neurovasc Res. 2018;15(3):226\u201333. https:\/\/doi.org\/10.2174\/1567202615666180712100440.","journal-title":"Curr Neurovasc Res"},{"issue":"2","key":"3617_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000328238","volume":"32","author":"A Stokowska","year":"2011","unstructured":"Stokowska A, Olsson S, Holmegaard L, et al. Plasma C3 and C3a levels in cryptogenic and large-vessel disease stroke: associations with outcome. Cerebrovasc Dis. 2011;32(2):114\u201322. https:\/\/doi.org\/10.1159\/000328238.","journal-title":"Cerebrovasc Dis"},{"issue":"3","key":"3617_CR30","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1161\/STROKEAHA.120.031715","volume":"52","author":"P Yang","year":"2021","unstructured":"Yang P, Zhu Z, Zang Y, et al. Increased serum complement C3 levels are associated with adverse clinical outcomes after ischemic stroke. Stroke. 2021;52(3):868\u201377. https:\/\/doi.org\/10.1161\/STROKEAHA.120.031715.","journal-title":"Stroke"},{"issue":"2","key":"3617_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11239-014-1100-7","volume":"39","author":"B Zhang","year":"2015","unstructured":"Zhang B, Yang N, Gao C. Is plasma C3 and C4 levels useful in young cerebral ischemic stroke patients? Associations with prognosis at 3 months. J Thromb Thrombolysis. 2015;39(2):209\u201314. https:\/\/doi.org\/10.1007\/s11239-014-1100-7.","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"3617_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1586\/14737175.2015.1013465","volume":"15","author":"A Bunevicius","year":"2015","unstructured":"Bunevicius A, Iervasi G, Bunevicius R. Neuroprotective actions of thyroid hormones and low-T3 syndrome as a biomarker in acute cerebrovascular disorders. Expert Rev Neurother. 2015;15(3):315\u201326. https:\/\/doi.org\/10.1586\/14737175.2015.1013465.","journal-title":"Expert Rev Neurother"},{"key":"3617_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13044-015-0021-7","volume":"8","author":"LM O'Keefe","year":"2015","unstructured":"O\u2019Keefe LM, Conway SE, Czap A, et al. Thyroid hormones and functional outcomes after ischemic stroke. Thyroid Res. 2015;8:9. https:\/\/doi.org\/10.1186\/s13044-015-0021-7.","journal-title":"Thyroid Res"},{"key":"3617_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clineuro.2018.03.025","volume":"169","author":"N Lamba","year":"2018","unstructured":"Lamba N, Liu C, Zaidi H, et al. A prognostic role for low tri-iodothyronine syndrome in acute stroke patients: a systematic review and meta-analysis. Clin Neurol Neurosurg. 2018;169:55\u201363. https:\/\/doi.org\/10.1016\/j.clineuro.2018.03.025.","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"3617_CR35","first-page":"205","volume":"37","author":"S Immanuel","year":"2005","unstructured":"Immanuel S, Giantini A, Dharma RS, Samino. The role of persistent anticardiolipin antibody as risk factor of ischemic stroke. Acta Med Indones. 2005;37(4):205\u20139.","journal-title":"Acta Med Indones"},{"issue":"8","key":"3617_CR36","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1093\/rheumatology\/kez551","volume":"59","author":"S Dong","year":"2020","unstructured":"Dong S, Pei B, Xie W, Wang J, Zeng Q. Anticardiolipin antibody and anti-\u03b22 glycoprotein I antibody are potential risk markers of ischaemic stroke in Chinese adults. Rheumatology. 2020;59(8):1834\u201341. https:\/\/doi.org\/10.1093\/rheumatology\/kez551.","journal-title":"Rheumatology"},{"issue":"7","key":"3617_CR37","first-page":"783","volume":"59","author":"T Imaizumi","year":"2007","unstructured":"Imaizumi T. Clinical significance of cerebral microbleed and its diagnostic criteria. Brain Nerve. 2007;59(7):783\u201391.","journal-title":"Brain Nerve"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03617-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03617-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03617-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T17:19:06Z","timestamp":1767633546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03617-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3617"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03617-w","relation":{},"ISSN":["2047-783X"],"issn-type":[{"type":"electronic","value":"2047-783X"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from Ethics Committee of the Second Affiliated Hospital of Harbin Medical University (KY2022-055).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}